Published in Microsurgery on May 01, 2010
Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol (2010) 2.38
The liver works as a school to educate regulatory immune cells. Cell Mol Immunol (2013) 0.86
Human hepatic stellate cells inhibit T-cell response through B7-H1 pathway. Transplantation (2013) 0.84
Hepatic immune tolerance induced by hepatic stellate cells. World J Gastroenterol (2015) 0.76
Immunological aspects of liver cell transplantation. World J Transplant (2016) 0.75
Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity (1995) 10.59
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med (1999) 9.78
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis. Blood (2005) 2.21
Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology (2004) 1.92
Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res (2001) 1.91
Orthotopic liver transplantation in the mouse. Transplantation (1991) 1.82
Characterization of two receptors for TRAIL. FEBS Lett (1997) 1.82
Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol (1997) 1.81
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med (2000) 1.77
In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology (2006) 1.63
Split tolerance induced by orthotopic liver transplantation in mice. Transplantation (1994) 1.52
Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells. Eur J Immunol (1998) 1.40
TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege. J Immunol (1999) 1.25
Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis. J Immunol (2001) 1.22
New insights into mechanisms of spontaneous liver transplant tolerance: the role of Foxp3-expressing CD25+CD4+ regulatory T cells. Am J Transplant (2008) 1.14
Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice. Diabetes (2003) 1.13
A functional model of hepatocyte transplantation for in vivo immunologic studies. Transplantation (1998) 1.13
CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis. J Clin Invest (2003) 1.10
The effect of portacaval shunt on delayed-hypersensitivity responses following antigen feeding. J Surg Res (1989) 1.03
A novel anti-human DR5 monoclonal antibody with tumoricidal activity induces caspase-dependent and caspase-independent cell death. J Biol Chem (2005) 1.03
Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance. Surgery (1994) 0.99
IFNgamma sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by upregulating Bak expression. Oncogene (2004) 0.95
In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model. Transplantation (1998) 0.95
Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses. Hepatology (1998) 0.93
Death ligand tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis. Endocrinology (2005) 0.91
TRAIL/Apo-2 ligand induces primary plasma cell apoptosis. J Immunol (2002) 0.89
TRAIL and immunity: more than a license to kill tumor cells. Cell Death Differ (2004) 0.84
Tolerogenic immunosuppression for organ transplantation. Lancet (2003) 4.09
A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med (2006) 3.16
A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C. Liver Transpl (2002) 2.07
Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl (2006) 2.02
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg (2005) 1.93
Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology (2004) 1.92
Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl (2005) 1.79
Management of patients with stercoral perforation of the sigmoid colon: report of five cases. World J Gastroenterol (2006) 1.73
In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology (2006) 1.63
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl (2005) 1.61
Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis. Clin Gastroenterol Hepatol (2012) 1.56
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52
Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology (2011) 1.44
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation (2004) 1.43
Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J Immunol (2002) 1.32
Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury. J Leukoc Biol (2006) 1.27
Porcine partial liver transplantation: a novel model of the "small-for-size" liver graft. Liver Transpl (2004) 1.22
Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology (2002) 1.21
Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner. Transplantation (2008) 1.20
Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. J Biol Chem (2001) 1.18
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation (2003) 1.18
Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol (2002) 1.17
Mechanistic insights into immunomodulation by hepatic stellate cells in mice: a critical role of interferon-gamma signaling. Hepatology (2009) 1.16
Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity. Diabetes (2003) 1.15
Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol (2006) 1.12
The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl (2002) 1.11
Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells. Transplantation (2012) 1.09
Immunosuppressive effects of glucosamine. J Biol Chem (2002) 1.08
Interaction between Rice stripe virus disease-specific protein and host PsbP enhances virus symptoms. Mol Plant (2013) 1.07
Dental health status of liver transplant candidates. Liver Transpl (2007) 1.05
Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. HPB (Oxford) (2005) 1.04
A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection. BMC Immunol (2012) 1.02
Transcriptome analysis of Chlamydomonas reinhardtii during the process of lipid accumulation. Genomics (2013) 1.02
Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury. Transplantation (2002) 0.99
Themes of liver transplantation. Hepatology (2010) 0.98
Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center's experience. Transplantation (2004) 0.97
Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl (2003) 0.97
Influence of cold ischemia time and graft transport distance on postoperative outcome in human liver transplantation. Surg Today (2002) 0.95
Growth factor-induced mobilization of dendritic cells in kidney and liver of rhesus macaques: implications for transplantation. Transplantation (2007) 0.95
Lessons of organ-induced tolerance learned from historical clinical experience. Transplantation (2004) 0.94
The role and potential therapeutic application of myeloid-derived suppressor cells in TNBS-induced colitis. J Leukoc Biol (2013) 0.92
Differential modulation of CD4 and CD8 T-cell proliferation by induction of nitric oxide synthesis in antigen presenting cells. Transplantation (2002) 0.92
Caroli's disease and orthotopic liver transplantation. Liver Transpl (2006) 0.92
The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood (2013) 0.92
The role of IL-6 in the radiation response of prostate cancer. Radiat Oncol (2013) 0.91
Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. Transplantation (2004) 0.91
Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity. Ann Surg (2005) 0.91
Iatrogenic femoral neuropathy following pelvic surgery: a rare and often overlooked complication--four case reports and literature review. Chang Gung Med J (2007) 0.90
Factor VIII-pulsed dendritic cells reduce anti-factor VIII antibody formation in the hemophilia A mouse model. Exp Hematol (2009) 0.90
Present state of immunosuppressive therapy in liver transplant recipients. Liver Transpl (2011) 0.90
A comparative study on suture versus cuff anastomosis in mouse cervical cardiac transplant. Exp Clin Transplant (2010) 0.90
Metabolic Signatures of Kidney Yang Deficiency Syndrome and Protective Effects of Two Herbal Extracts in Rats Using GC/TOF MS. Evid Based Complement Alternat Med (2013) 0.90
Four-color flow cytometric analysis of peripheral blood donor cell chimerism. Hum Immunol (2003) 0.89
Cotransplanted hepatic stellate cells enhance vascularization of islet allografts. Microsurgery (2007) 0.89
Intrahepatic biliary anatomy of living adult liver donors: correlation of mangafodipir trisodium-enhanced MR cholangiography and intraoperative cholangiography. AJR Am J Roentgenol (2002) 0.89
Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center. Transplantation (2005) 0.89
Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27. J Hepatol (2009) 0.88
Graded function of CD80 and CD86 in initiation of T-cell immune response and cardiac allograft survival. Transpl Int (2007) 0.88
Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis. Invest Ophthalmol Vis Sci (2012) 0.88
Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients. Liver Transpl (2003) 0.88
Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors. J Hepatol (2002) 0.88
Phenytoin decreases the blood concentrations of sirolimus in a liver transplant recipient: a case report. Ther Drug Monit (2003) 0.87